Matthew Angel

Chief Executive Officer, Ernexa Therapeutics Inc.

Companies

Tempest Therapeutics, Inc.Board member Feb 6, 2026 to now¹
Tempest Therapeutics, Inc.Chief executive officer Feb 6, 2026 to now¹
Tempest Therapeutics, Inc.President Feb 6, 2026 to now¹
Ernexa Therapeutics Inc.Board member Aug 3, 2022 to Jan 13, 2023²
Ernexa Therapeutics Inc.Chief executive officer Jun 1, 2022 to Jan 13, 2023³
Ernexa Therapeutics Inc.President Jun 1, 2022 to Jan 13, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Ernexa Therapeutics Inc. ERNA3,489,666 shares⁴$7.2M at $2.05Jun 1, 2022
Tempest Therapeutics, Inc. TPST5,068,552 shares⁵$3.1M at $0.60Mar 25, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 24, 2026Bought 231,482 shares at $2.16 of Tempest Therapeutics, Inc.⁵
Mar 24, 2026Bought 231,482 shares at $2.16 of Tempest Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTempest Therapeutics, Inc., Board member
2
SEC EDGARErnexa Therapeutics Inc., Board member
3
SEC EDGARErnexa Therapeutics Inc., Chief executive officer
4
SEC EDGARErnexa Therapeutics Inc. shares after the filing of Jun 1, 2022
5
SEC EDGARTempest Therapeutics, Inc. shares after the filing of Mar 25, 2026
6
SEC EDGARForm 4 filed Jun 23, 2026